Table 1

Demographic details of the patients included in the study (n=36)

ParametersDataTreatment firstSham firstp Value
Age (years)50.8 (11.2)51.2 (11.9)50.6 (11)0.89
Sex (males/females)30/613/117/50.22
White British, n (%)29 (80.5)12 (85.7)17 (77.2)<0.05
Caribbean, n (%)3 (8.3)1 (7.1)2 (9.1)0.83
African, n (%)2 (5.5)1 (7.1)1 (4.5)0.74
Indian, n (%)1 (2.7)01 (4.5)0.41
White other, n (%)1 (2.7)01 (4.5)0.41
Height (cm)175.3 (8.4)175.6 (6.4)175.1 (9.6)0.83
Weight (kg)95.8 (17.7)93.8 (17.7)97.1 (18.1)0.59
BMI (kg/m2)*29.7 (26.9–34.9)28.4 (26.6–35)30.6 (27.4–34.9)0.44
Neck circumference (cm)42.6 (3.8)42.0 (2.9)42.9 (4.2)0.42
Waist circumference (cm)103.8 (16.5)104.4 (14.1)103.4 (18.2)0.85
Hip circumference (cm)*105.0 (99.0–111.0)107.2 (99.8–111.0)104.5 (98.3–108.0)0.26
Waist:hip ratio0.99 (0.08)0.98 (0.07)1.00 (0.08)0.29
Mallampati score I, n (%)8 (22.2)4 (28.5)4 (18.1)0.56
Mallampati score II, n (%)15 (41.6)4 (28.5)11 (50)0.2
Mallampati score III, n (%)8 (22.2)5 (35.7)3 (13.6)0.12
Mallampati score IV, n (%)5 (13.8)1 (7.1)4 (18.1)0.35
ESS (points)10.5 (4.6)11.4 (4.6)10 (4.5)0.39
FEV1 (L)3.13 (0.82)2.94 (0.73)3.25 (0.86)0.26
FVC (L)4.08 (0.89)3.89 (0.86)4.20 (1.07)0.34
FEV1/FVC (%)76.8 (8.2)75.7 (9.9)77.4 (7.0)0.58
SpO2 awake (%)94.6 (1.0)94.7 (0.6)94.5 (1.2)0.43
Previous treatment: none/CPAP, n (%)18 (50.0)/18 (50.0)7 (50.0)/7 (50.0)11 (50.0)/11 (50.0)1.0
Alcohol consumption (units/week)*2.0 (0.0–10.5)1 (0.0–5.9)4 (0–11.5)0.49
Pack-years (years)* (12 lifelong non-smokers, 24 current or ex-smokers)10.0 (5.0–14.3)10.0 (6.5–12.1)10.0 (5–15)0.55
  • *Data were non-normally distributed and are expressed as median and IQR. Pack-years are calculated for current and ex-smokers only (n=24).

  • BMI, body mass index; ESS, Epworth Sleepiness Scale; SpO2: oxygen saturation.